Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Management of implantable cardioverter defibrillators in end-of-life care.

Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM.

Ann Intern Med. 2004 Dec 7;141(11):835-8.

PMID:
15583224
[PubMed - indexed for MEDLINE]
2.

Summaries for patients. Implantable cardioverter defibrillators and end-of-life care.

[No authors listed]

Ann Intern Med. 2004 Dec 7;141(11):I38. No abstract available.

PMID:
15583220
[PubMed - indexed for MEDLINE]
3.

Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.

Mueller PS, Jenkins SM, Bramstedt KA, Hayes DL.

Pacing Clin Electrophysiol. 2008 May;31(5):560-8. doi: 10.1111/j.1540-8159.2008.01041.x.

PMID:
18439169
[PubMed - indexed for MEDLINE]
4.

Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Marinskis G, van Erven L; EHRA Scientific Initiatives Committee.

Europace. 2010 Aug;12(8):1176-7. doi: 10.1093/europace/euq272.

PMID:
20663788
[PubMed - indexed for MEDLINE]
Free Article
5.

"That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.

Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, Bradley EH, Morrison RS.

J Gen Intern Med. 2008 Jan;23 Suppl 1:7-12. doi: 10.1007/s11606-007-0239-8.

PMID:
18095037
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.

Russo JE.

Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91. Review.

PMID:
21926561
[PubMed - indexed for MEDLINE]
7.

End of life management of adult patients in an Australian metropolitan intensive care unit: A retrospective observational study.

Bloomer MJ, Tiruvoipati R, Tsiripillis M, Botha JA.

Aust Crit Care. 2010 Feb;23(1):13-9. doi: 10.1016/j.aucc.2009.10.002. Epub 2009 Nov 14.

PMID:
19914844
[PubMed - indexed for MEDLINE]
8.

Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.

Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ.

Am J Cardiol. 2012 Jan 1;109(1):91-4. doi: 10.1016/j.amjcard.2011.08.011. Epub 2011 Sep 22.

PMID:
21943937
[PubMed - indexed for MEDLINE]
9.

Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey.

Davids JS, McPherson CA, Earley C, Batsford WP, Lampert R.

Arch Phys Med Rehabil. 2005 Oct;86(10):1924-8.

PMID:
16213232
[PubMed - indexed for MEDLINE]
10.

Management of patients with ICDs at the end of life (EOL): a qualitative study.

Kelley AS, Mehta SS, Reid MC.

Am J Hosp Palliat Care. 2008 Dec-2009 Jan;25(6):440-6. doi: 10.1177/1049909108320885. Epub 2008 Sep 23.

PMID:
18812618
[PubMed - indexed for MEDLINE]
11.

Next-of-kin responses and do-not-resuscitate implications for implantable cardioverter defibrillators.

Morrison LJ, Sinclair CT.

Ann Intern Med. 2005 Apr 19;142(8):676-7; author reply 677. No abstract available.

PMID:
15838078
[PubMed - indexed for MEDLINE]
12.

End-of-life decisions in ICD patients with malignant tumors.

Kobza R, Erne P.

Pacing Clin Electrophysiol. 2007 Jul;30(7):845-9.

PMID:
17584265
[PubMed - indexed for MEDLINE]
13.

Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators.

Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, Calkins H, Donahue JK.

Heart Rhythm. 2006 Jul;3(7):762-8. Epub 2006 Mar 27.

PMID:
16818202
[PubMed - indexed for MEDLINE]
14.

"It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.

Goldstein NE, Mehta D, Teitelbaum E, Bradley EH, Morrison RS.

J Gen Intern Med. 2008 Jan;23 Suppl 1:2-6. doi: 10.1007/s11606-007-0237-x.

PMID:
18095036
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
16.

End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.

Sherazi S, McNitt S, Aktas MK, Polonsky B, Shah AH, Moss AJ, Daubert JP, Zareba W.

Pacing Clin Electrophysiol. 2013 Oct;36(10):1273-9. doi: 10.1111/pace.12188. Epub 2013 Jun 3.

PMID:
23731284
[PubMed - indexed for MEDLINE]
17.

Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.

Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS.

Am Heart J. 2009 Apr;157(4):702-8.e1. doi: 10.1016/j.ahj.2008.12.011. Epub 2009 Feb 23.

PMID:
19332199
[PubMed - indexed for MEDLINE]
18.

Managing cardiac devices near the end of life: a survey of hospice and palliative care providers.

Morrison LJ, Calvin AO, Nora H, Porter Storey C Jr.

Am J Hosp Palliat Care. 2010 Dec;27(8):545-51. doi: 10.1177/1049909110373363. Epub 2010 Aug 16.

PMID:
20713422
[PubMed - indexed for MEDLINE]
19.

Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.

Niewald A, Broxterman J, Rosell T, Rigler S.

J Med Ethics. 2013 Feb;39(2):94-7. doi: 10.1136/medethics-2012-100613. Epub 2012 Nov 8.

PMID:
23139392
[PubMed - indexed for MEDLINE]
20.

Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR.

Am J Cardiol. 2007 Sep 15;100(6):924-9. Epub 2007 Jun 27.

PMID:
17826371
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk